Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-2,013
Closed -$190K – 176
2019
Q1
$190K Buy
+2,013
New +$176K 0.21% 60
2018
Q4
– Sell
-2,083
Closed -$186K – 264
2018
Q3
$186K Buy
2,083
+50
+2% +$4.42K 0.17% 64
2018
Q2
$161K Buy
+2,033
New +$169K 0.15% 70

Other funds holding CELG

WP Advisors's CELG Position: Q2 2019 in Review

WP Advisors sold out of Celgene (CELG) in Q2 2019, closing a stake of 2,013 shares — an estimated $190K sold.

WP Advisors first reported a position in CELG in Q2 2018 and held it in 3 quarters. The position peaked at $190K in Q1 2019. 1,289 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • WP Advisors reported no remaining Celgene position as of Q2 2019 after selling out during the quarter.
  • WP Advisors sold 2,013 Celgene shares in Q2 2019, an estimated $190K.
  • WP Advisors first reported a position in Celgene in Q2 2018 and held it in 3 quarters.
  • WP Advisors's Celgene position peaked at $190K in Q1 2019.
  • 1,289 funds tracked by Wall St. Rank held Celgene as of Q2 2019.

Based on WP Advisors's 13F filing for Q2 2019, filed 23 Jul 2019.